nicholasmg

Neuroscientist analyzing biotech companies through clinical trials, patents & SEC filings. Building

[nicholasmg @nicholasMG]

JPM Healthcare opening day is the most disclosure-heavy day in biotech.

[nicholasmg @nicholasMG]

Clinical trial sponsors are a mess of aliases, subsidiaries, and rebrands. I built a harmonization pipeline that links them to SEC filings using GPT-4o and a validation layer.

Real CI starts with clean data.
https://t.co/W7Olfl3Ka9
#biotech #investing #clinicaltrials